Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Protox commences placebo-controlled phase II BPH study

Jan. 15, 2009

Plexxikon and Roche partner to develop PLX-5568 for polycystic kidney disease

Jan. 9, 2009

Daiichi files application for KMD-3212 in China for dysuria

Jan. 9, 2009

BioXell completes patient enrollment in phase IIb clinical trial of elocalcitol in OAB

Dec. 22, 2008

NX-1207 shows significantly less sleep interruption for men with BPH

Dec. 19, 2008

AEterna Zentaris completes patient recruitment into phase III safety trial of cetrorelix in BPH

Dec. 19, 2008

Omeros presents results from phase I OMS-201 study

Dec. 12, 2008

New treatment options for genitourinary disorders reported in recent Japanese patents

Dec. 11, 2008

EA-230 attenuates acute renal failure in vivo

Dec. 3, 2008

ONO-1301MS may improve tubulointerstitial injury in chronic kidney disease

Dec. 2, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...